The U.S. Food and Drug Administration (FDA) announced that Hospira initiated a class I recall of the Symbiq infusion pump system touchscreen because the device might not respond to user selections, which can cause life-threatening side effects.
What Is the Symbiq Infusion Pump?
Hospira’s Symbiq infusion pump is a prescription device that delivers medications to patients intravenously and through other avenues. Medical professionals can use the infusion pump’s touchscreen to control the dosage and speed medication is delivered to the patient.
The Symbiq Infusion Pump Might Cause Life-Threatening Side Effects
On August 29, 2012, Hospira sent an “Urgent Device Correction” letter to Symbiq infusion pump customers that it had received reports that the device’s touchscreen failed to respond to user selections, exhibited a delayed response, or registered a different selection from the user’s inputs. Hospira noted that if the user does not confirm the values displayed in the confirmation screen, the following outcomes could occur:
- Delay in therapy
- Over-delivery of medication
- Under-delivery of medication
Because the Symbiq infusion pump system can deliver life-saving medication, these outcomes can cause life-threatening side effects. Hospira did not request customers return their Symbiq infusion pumps, but it did promise to correct any software bugs that caused the touchscreen to mis-respond to users’ selections. All serial numbers for the model 16026 Symbiq One Channel Infuser and 16027 Symbiq Two Channel Infuser were affected by the recall, which the FDA reported on October 29, 2012.
Later, in November 2012, Hospira admitted in a regulatory filing that the FDA prohibited it from importing new Symbiq infusion pumps into the United States from its manufacturing facilities in Costa Rica.
RLG’s Symbiq Infusion Pump Lawyers Will Make Things Easier
The process of demanding compensation for the harm you’ve suffered can be complicated, even if it doesn’t seem fair that you should have to go through even more trouble to be made whole again. The Symbiq infusion pump lawyers at the Rottenstein Law Group believe that obtaining legal satisfaction from those who harmed you shouldn’t require more hardship. That’s why we do everything we can to streamline the process, and we will file a Symbiq infusion pump lawsuit on your behalf if necessary. RLG will also keep you up to date on any Symbiq infusion pump class action lawsuits, FDA Symbiq infusion pump warnings, and additional Symbiq infusion pump FDA recall announcements. If you believe the malfunction of a Symbiq infusion pump injured you or a loved one, contact RLG today.